Fujian Wanchen Biotechnology Co. Ltd300972
▲ PositiveCapitalDemandrelevance
H1 net profit up 156.58% YoY with revenue up 54.26% and a planned cash dividend of 1.5 yuan per 10 shares.

Wanchen Group disclosed its 2026 interim report on August 28. During the reporting period, the company achieved total operating revenue of 34.836 billion yuan, up 54.26% year on year. Net profit attributable to shareholders of the listed company was 1.21 billion yuan, up 156.58% year on year. Basic earnings per share were 6.3021 yuan. The company plans to distribute a cash dividend of 1.5 yuan per 10 shares, tax included. In the first half of 2026, the company added a cumulative 5,814 new stores and closed 326, bringing the total number of stores to 23,802 as of June 30.
Fujian Wanchen Biotechnology Co. LtdH1 net profit up 156.58% YoY with revenue up 54.26% and a planned cash dividend of 1.5 yuan per 10 shares.